Incidence, pathophysiology, and clinical manifestations of antiphospholipid syndrome

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 105, Issue 3, 2015, Pages 201-208

  Brock, Clifton O'neill ^a   Brohl, Andrew Scott ^b   Običan, Sarah Gloria ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antiphospholipid syndrome; Maternal fetal medicinel high risk pregnancy; Thrombosis

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; HEART DISEASE; HIGH RISK POPULATION; HUMAN; INCIDENCE; KIDNEY DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; RECURRENT ABORTION; REVIEW; THROMBOSIS; FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; INCIDENCE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84942511383     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.21107     Document Type: Review

References (84)

1. Abalos E, Cuesta C, Grosso AL, et al. 2013. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 170:1-7.
2. Alegre VA, Gastineau DA, Winkelmann RK. 1989. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 120:419-429.
3. Andersen AMN, Wohlfahrt J, Christens P, et al. 2000. Maternal age and fetal loss: population based register Linkage study. Br Med J 320:1708-1712.
4. Appenzeller S, Souza FH, Wagner Silva de Souza A, et al. 2011. HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies. Semin Arthritis Rheum 41:517-523.
5. Balasch J, Creus M, Fabregues F, et al. 1996. Antiphospholipid antibodies and human reproductive failure. Hum Reprod 11:2310-2315.
6. Bates SM, Greer IA, Pabinger I, et al. 2008. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:844s-886s.
7. Branch DW, Andres R, Digre KB, et al. 1989. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 73:541-545.
8. Branch DW, Peaceman AM, Druzin M, et al. 2000. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182:122-127.
9. Branch DW, Silver RM, Blackwell JL, et al. 1992. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80:614-620.
10. Branch DW, Silver RM, Porter TF. 2010. Obstetric antiphospholipid syndrome: current uncertainties should guide our way. Lupus 19:446-452.
11. Brey RL, Stallworth CL, McGlasson DL, et al. 2002. Antiphospholipid antibodies and stroke in young women. Stroke 33:2396-2400.
12. Cervera R, Khamashta MA, Shoenfeld Y, et al. 2009. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 68:1428-1432.
13. Cervera R, Piette JC, Font J, et al. 2005. "Euro-phospholipid" project: 5-year prospective study of morbidity and mortality in a cohort of 1, 000 patients with the antiphospholipid syndrome (APS). Arthritis Rheum 52:4065-4066.
14. Cervera R, Piette JC, Font J, et al. 2002. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients. Arthritis Rheum 46:1019-1027.
15. Cervera R, Rodriguez-Pinto I, Espinosa G, Task Force C. 2014. Catastrophic antiphospholipid syndrome: task force report summary. Lupus 23:1283-1285.
16. Cervera R, Tektonidou MG, Espinosa G, et al. 2011. Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 20:165-173.
17. Clark EA, Silver RM, Branch DW. 2007. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 9:219-225.
18. Committee on Practice Bulletins. Obstetrics, American College of Obstetricians and Gynecologists. 2012. Practice bulletin No. 132: Antiphospholipid syndrome. Obstet Gynecol 120: 1514-1521.
19. de Godoy JM, de Godoy MR, Cipulo JP, Tognola VA. 2005. Vascular dementia and anticardiolipin antibodies. Med Sci Monitor 11:Cr430-Cr433.
20. Dendrinos S, Sakkas E, Makrakis E. 2009. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Int J Gynaecol Obstet 104:223-225.
21. Derksen RH, Khamashta MA, Branch DW. 2004. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028-1039.
22. do Prado AD, Piovesan DM, Staub HL, Horta BL. 2010. Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstet Gynecol 116:1433-1443.
23. Drakeley AJ, Quenby S, Farquharson RG. 1998. Mid-trimester loss - appraisal of a screening protocol. Hum Reprod 13:1975-1980.
24. Dreyfus M, Hedelin G, Kutnahorsky R, et al. 2001. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet Gynecol 97:29-34.
25. Erkan D, Aguiar CL, Andrade D, et al. 2014. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 13:685-696.
26. Erkkila AT, Narvanen O, Lehto S, et al. 2000. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 20:204-209.
27. Erkkila AT, Narvanen O, Lehto S, et al. 2005. Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease. Atherosclerosis 183:157-162.
28. Faden D, Tincani A, Tanzi P, et al. 1997. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 73:37-42.
29. Farquharson RG, Quenby S, Greaves M. 2002. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100:408-413.
30. Gibson GE, Su WP, Pittelkow MR. 1997. Antiphospholipid syndrome and the skin. J Am Acad Dermatol 36:970-982.
31. Girardi G, Redecha P, Salmon JE. 2004. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10:1222-1226.
32. Gomez-Puerta JA, Cervera R. 2014. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun 4849:20-25.
33. Gomez-Puerta JA, Cervera R, Espinosa G, et al. 2007. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis 66:740-746.
34. Heilmann L, Schorsch M, Hahn T, Fareed J. 2011. Antiphospholipid syndrome and pre-eclampsia. Semin Thromb Hemost 37:141-145.
35. Janardhan V, Wolf PA, Kase CS, et al. 2004. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke 35:736-741.
36. Kutteh WH. 1996. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174:1584-1589.
37. Laskin CA, Spitzer KA, Clark CA, et al. 2009. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 36:279-287.
38. Lee RM, Brown MA, Branch DW, et al. 2003. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 102:294-300.
39. Levine SR, Welch KM. 1987. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 44:876-883.
40. Lim W, Crowther MA, Eikelboom JW. 2006. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295:1050-1057.
41. Lima F, Khamashta MA, Buchanan NMM, et al. 1996. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14:131-136.
42. Lockshin MD, Druzin ML, Qamar T. 1989. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 160:439-443.
43. Mak A, Cheung MW, Cheak AA, Ho RC. 2010. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive antiphospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford, England) 49:281-288.
44. Malm J, Laurell M, Nilsson IM, Dahlback B. 1992. Thromboembolic disease-critical evaluation of laboratory investigation. Thromb Haemost 68:7-13.
45. Mello G, Parretti E, Marozio L, et al. 2005. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 46:1270-1274.
46. Meroni PL, Ronda N, De Angelis V, et al. 2007. Role of anti-beta(2) glycoprotein I antibodies in anti phospholipid syndrome - in vitro and in vivo studies. Clin Rev Allergy Immunol 32:67-73.
47. Mezzesimi A, Florio P, Reis FM, et al. 2007. The detection of anti-beta 2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester. Eur J Obstet Gynecol Reprod Biol 133:164-168.
48. Mialdea M, Sangle SR, D'Cruz DP. 2009. Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. J Autoimmun Dis 6:3.
49. Miyakis S, Lockshin MD, Atsumi T, et al. 2006. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306.
50. Moodley J, Bhoola V, Duursma J, et al. 1995. The association of antiphospholipid antibodies with severe early-onset pre-eclampsia. South Afr Med J 85:105-107.
51. Mulla MJ, Myrtolli K, Brosens JJ, et al. 2010. Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity. Am J Reprod Immunol 63:339-348.
52. Munts AG, van Genderen PJ, Dippel DW, et al. 1998. Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol 245:21-25.
53. Nochy D, Daugas E, Droz D, et al. 1999. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507-518.
54. Nodler J, Moolamalla SR, Ledger EM, et al. 2009. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy Childbirth 9:11.
55. Ortel TL. 2005. Thrombosis and the antiphospholipid syndrome. Hematology 462-468.
56. Oshiro BT, Silver RM, Scott JR, et al. 1996. Antiphospholipid antibodies and fetal death. Obstet Gynecol 87:489-493.
57. Pattison NS, Chamley LW, Birdsall M, et al. 2000. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 183:1008-1012.
58. Petri M. 2000. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 15:145-151.
59. Pons-Estel GJ, Cervera R. 2014. Renal involvement in antiphospholipid syndrome. Curr Rheumatol Rep 16:397-
60. Rai R, Cohen H, Dave M, Regan L. 1997. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ (Clin Res Ed) 314:253-257.
61. Rai RS, Regan L, Clifford K, et al. 1995. Antiphospholipid antibodies and beta-2-glycoprotein-i in 500 women with recurrent miscarriage - results of a comprehensive screening approach. Hum Reprod 10:2001-2005.
62. Rand JH, Wu XX, Andree HAM, et al. 1997. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 337:154-160.
63. Robertson L, Wu O, Langhorne P, et al. 2006. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132:171-196.
64. Rosove MH, Brewer PM. 1992. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117:303-308.
65. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. 2010. Antiphospholipid syndrome. Lancet 376:1498-1509.
66. Sangle SR, D'Cruz DP, Jan W, et al. 2003. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis 62:999-1002.
67. Shoenfeld Y, Meroni PL, Toubi E. 2009. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale? Curr Opin Rheumatol 21:495-500.
68. Silver RK, MacGregor SN, Sholl JS, et al. 1993. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 169:1411-1417.
69. Silver RM, Draper ML, Scott JR, et al. 1994. Clinical consequences of antiphospholipid antibodies - an historic cohort study. Obstet Gynecol 83:372-377.
70. Silver RM, Parker CB, Reddy UM, et al. 2013. Antiphospholipid antibodies in stillbirth. Obstet Gynecol 122:641-657.
71. Sneddon IB. 1965. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 77:180-185.
72. Stirrat GM. 1990. Recurrent miscarriage.1. Definition and epidemiology. Lancet 336:673-675.
73. Tektonidou MG, Varsou N, Kotoulas G, et al. 2006. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 166:2278-2284.
74. Urbanus RT, Siegerink B, Roest M, et al. 2009. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 8:998-1005.
75. Veres K, Lakos G, Kerenyi A, et al. 2004. Antiphospholipid antibodies in acute coronary syndrome. Lupus 13:423-427.
76. Vinatier D, Dufour P, Cosson M, Houpeau JL. 2001. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 96:37-50.
77. Wilson WA, Gharavi AE, Koike T, et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome - report of an international workshop. Arthritis Rheum 42:1309-1311.
78. Yamada H, Atsumi T, Kobashi G, et al. 2009. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol 79:188-195.
79. Yang CJ, Stone P, Stewart AW. 2006. The epidemiology of recurrent miscarriage: a descriptive study of 1214 prepregnant women with recurrent miscarriage. Aust N Z J Obstet Gynaecol 46:316-322.
80. Yetman DL, Kutteh WH. 1996. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 66:540-546.
81. Ziakas PD, Pavlou M, Voulgarelis M. 2010. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 115:1256-1262.
82. Zinger H, Sherer Y, Goddard G, et al. 2009. Common infectious agents prevalence in antiphospholipid syndrome. Lupus 18:1149-1153.
83. Zuily S, Huttin O, Mohamed S, et al. 2013. Valvular heart disease in antiphospholipid syndrome. Curr Rheumatol Rep 15:320
84. Zuily S, Regnault V, Selton-Suty C, et al. 2011. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation 124:215-224.